ARGENETICS
USPTO Trademark Record · Serial No. 86448376
Trademark details
It was initially claimed by RMT-Epigenomex, Inc. on 20141107.
That brand applies to the following goods and services:ARGenetics The ARGenetics pre-clinical drug discovery platform is applicable to epigenetic drug development that involves protein arginine methylation as it applies to 5 major disease categories; cancer, neurodevelopmental, autoimmune, viral and cardiovascular diseases. We provide time and cost savings throughout the development pipeline, particularly in the earliest chemical compound screening stages; Depending upon the size of the chemical compound library that requires screening for effective.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the ARGENETICS trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
